Literature DB >> 21364469

Myocardial iron loading in patients with thalassemia major in Turkey and the potential role of splenectomy in myocardial siderosis.

Yesim Aydinok1, Selen Bayraktaroglu, Dilek Yildiz, Hudaver Alper.   

Abstract

Iron-induced cardiac disease is the leading cause of death in thalassemia major (TM). Splenectomy is performed in TM to reduce transfusion requirements and iron intake. Prevalence of myocardial siderosis and its relationship with splenectomy in 146 patients with TM were investigated. The patients with myocardial siderosis (T2*<20 ms) accounted for 42% of the cohort. Splenectomized patients had a higher incidence of myocardial siderosis (48%) compared with those having intact spleen (28%) and significantly higher myocardial iron content. Higher myocardial iron content in splenectomized patients may deserve special attention for the role of spleen in iron regulation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21364469     DOI: 10.1097/MPH.0b013e31820c34ef

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN: 1077-4114            Impact factor:   1.289


  9 in total

1.  Splenectomy for β-Thalassemia Major in Resource Challenged Settings: Often a Hobson's Choice!

Authors:  Deepak Bansal
Journal:  Indian J Pediatr       Date:  2015-08-29       Impact factor: 1.967

2.  Increased mitochondrial DNA deletions and copy number in transfusion-dependent thalassemia.

Authors:  Ashutosh Lal; Esteban Gomez; Cassandra Calloway
Journal:  JCI Insight       Date:  2016-08-04

3.  New developments and controversies in iron metabolism and iron chelation therapy.

Authors:  Christina N Kontoghiorghe; George J Kontoghiorghes
Journal:  World J Methodol       Date:  2016-03-26

4.  Cardiac T2* MRI assessment in patients with thalassaemia major and its effect on the preference of chelation therapy.

Authors:  Arzu Akcay; Zafer Salcioglu; Kazim Oztarhan; Deniz Tugcu; Gonul Aydogan; Nuray Aktay Ayaz; Helen Bornaun; Hulya Sayilan Sen; Ferhan Akici; Burhan Akdana
Journal:  Int J Hematol       Date:  2014-04-10       Impact factor: 2.490

5.  Modern management of iron overload in thalassemia major patients guided by MRI techniques: real-world data from a long-term cohort study.

Authors:  Selen Bayraktaroglu; Nihal Karadas; Sebnem Onen; Deniz Yılmaz Karapinar; Yesim Aydinok
Journal:  Ann Hematol       Date:  2022-01-05       Impact factor: 3.673

Review 6.  The transfusion management of beta thalassemia in the United States.

Authors:  Ashutosh Lal; Trisha Wong; Siobán Keel; Monica Pagano; Jong Chung; Aditi Kamdar; Latha Rao; Alan Ikeda; Geetha Puthenveetil; Sanjay Shah; Jennifer Yu; Elliott Vichinsky
Journal:  Transfusion       Date:  2021-08-28       Impact factor: 3.337

7.  Heart involvement in transfusion-dependent beta-thalassemia with conventional echocardiography.

Authors:  Hossein Esfahani; Asadolah Tanasan; Mina Rezanejad; Saadat Torabian
Journal:  Caspian J Intern Med       Date:  2021-04

8.  Clinical and methodological factors affecting non-transferrin-bound iron values using a novel fluorescent bead assay.

Authors:  Maciej W Garbowski; Yongmin Ma; Suthat Fucharoen; Somdet Srichairatanakool; Robert Hider; John B Porter
Journal:  Transl Res       Date:  2016-06-07       Impact factor: 7.012

9.  Does growth differentiation factor 11 protect against myocardial ischaemia/reperfusion injury? A hypothesis.

Authors:  Yongjian Yang; Yi Yang; Xiong Wang; Jin Du; Juanni Hou; Juan Feng; Yue Tian; Lei He; Xiuchuan Li; Haifeng Pei
Journal:  J Int Med Res       Date:  2016-08-25       Impact factor: 1.671

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.